US Patent 8629157 Pyrrolidine compounds which modulate the CB2 receptor

Patent 8629157 was granted and assigned to Boehringer Ingelheim on January, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Boehringer Ingelheim

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8629157

Date of Patent

January 14, 2014

Patent Application Number

13141105

Date Filed

December 15, 2009

Patent Citations Received

‌

US Patent 11771682 AR+ breast cancer treatment methods

Patent Primary Examiner

‌

Alicia L Otton

Patent abstract

Compounds which modulate the CB2 receptor are disclosed. Compounds according to the invention bind to and are agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain (I).

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8629157 Pyrrolidine compounds which modulate the CB2 receptor

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API